Contact
searchSearch
HMP Global

Patient Myths

Guttman
Videos
Myth Buster: Alopecia Areata is Just Hair Loss
08/06/2026
Emma Guttman-Yassky, MD, PhD; Riya Gandhi, MA
Alopecia areata is more than hair loss. Dr Emma Guttman discusses the disease's psychosocial burden, autoimmune nature, and why viewing AA as purely cosmetic can undermine patient care.
Alopecia areata is more than hair loss. Dr Emma Guttman discusses the disease's psychosocial burden, autoimmune nature, and why viewing AA as purely cosmetic can undermine patient care.
Alopecia areata is more than...
08/06/2026
The Dermatologist
Brittany Craiglow
Videos
Myth Buster: Alopecia Areata is Contagious
08/06/2026
Brittany Craiglow, MD; Riya Gandhi, MA
Misconceptions about alopecia areata being contagious continue to fuel stigma. Dr Brittany Craiglow explains the autoimmune nature of the disease and shares practical strategies for patient education.
Misconceptions about alopecia areata being contagious continue to fuel stigma. Dr Brittany Craiglow explains the autoimmune nature of the disease and shares practical strategies for patient education.
Misconceptions about alopecia...
08/06/2026
The Dermatologist
Justin Ko
Videos
Myth Buster: Wearing Hats or Wigs Makes Alopecia Areata Worse
07/08/2026
Justin M. Ko, MD, MBA; Riya Gandhi, MA
Can hats or wigs worsen alopecia areata? Dr Justin Ko debunks this common myth and explains how protective hair coverings fit into patient care.
Can hats or wigs worsen alopecia areata? Dr Justin Ko debunks this common myth and explains how protective hair coverings fit into patient care.
Can hats or wigs worsen alopecia...
07/08/2026
The Dermatologist
Justin Ko
Videos
Myth Buster: Alopecia Areata Only Affects the Scalp
07/08/2026
Justin M. Ko, MD, MBA; Riya Gandhi, MA
Think alopecia areata only affects the scalp? Learn how eyebrows, eyelashes, nails, and body hair can also be affected by this autoimmune disease.
Think alopecia areata only affects the scalp? Learn how eyebrows, eyelashes, nails, and body hair can also be affected by this autoimmune disease.
Think alopecia areata only...
07/08/2026
The Dermatologist
Glynis Ablon
Videos
Myth Buster: Stress Causes Alopecia Areata
07/01/2026
Glynis Ablon; Riya Gandhi, MA
Does stress cause alopecia areata? Dr Glynis Ablon separates fact from fiction, explaining why alopecia areata is an autoimmune disease—not a stress-induced condition.
Does stress cause alopecia areata? Dr Glynis Ablon separates fact from fiction, explaining why alopecia areata is an autoimmune disease—not a stress-induced condition.
Does stress cause alopecia...
07/01/2026
The Dermatologist
ablon
Videos
Myth Buster: Alopecia Areata is Just Hair Loss
07/01/2026
Glynis Ablon; Riya Gandhi, MA
Is alopecia areata just hair loss? Dr Glynis Ablon explains why alopecia areata is a systemic autoimmune disease with far-reaching physical and emotional consequences.
Is alopecia areata just hair loss? Dr Glynis Ablon explains why alopecia areata is a systemic autoimmune disease with far-reaching physical and emotional consequences.
Is alopecia areata just hair...
07/01/2026
The Dermatologist
Ablon
Videos
Myth Buster: If Your Hair Grows Back, Alopecia Areata is Gone
07/01/2026
Glynis Ablon; Riya Gandhi, MA
Does hair regrowth mean alopecia areata is cured? Dr Glynis Ablon explains why hair regrowth does not signal the end of autoimmune activity.
Does hair regrowth mean alopecia areata is cured? Dr Glynis Ablon explains why hair regrowth does not signal the end of autoimmune activity.
Does hair regrowth mean alopecia...
07/01/2026
The Dermatologist

Popular Articles

PsA
FDA Alerts
Bimekizumab FDA Approved for the Treatment of Psoriatic Arthritis
09/24/2024
Riya Gandhi, MA
The US Food and Drug Administration (FDA) has approved UCB’s BIMZELX (bimekizumab-bkzx), an IL-17A and IL-17F inhibitor, for the treatment of adults with active psoriatic arthritis (PsA).
The US Food and Drug Administration (FDA) has approved UCB’s BIMZELX (bimekizumab-bkzx), an IL-17A and IL-17F inhibitor, for the treatment of adults with active psoriatic arthritis (PsA).
The US Food and Drug...
09/24/2024
The Dermatologist
psoriasis
News
Long-Term Risankizumab Treatment for Moderate to Severe Plaque Psoriasis
08/22/2024
Jessica Garlewicz
Researchers assessed the long-term efficacy of risankizumab for moderate to severe plaque psoriasis.
Researchers assessed the long-term efficacy of risankizumab for moderate to severe plaque psoriasis.
Researchers assessed the...
08/22/2024
The Dermatologist
Case Report
Successful Treatment of Melasma in Fitzpatrick Skin Type IV
10/07/2024
Monica Khadka, BA, BS; Kerry C. Hennessy, MD; Lilia M. Correa-Selm, MD, FAAD
Nonablative Alexandrite laser therapy may be an effective method of treating melasma in patients with darker skin types.
Nonablative Alexandrite laser therapy may be an effective method of treating melasma in patients with darker skin types.
Nonablative Alexandrite laser...
10/07/2024
The Dermatologist
Clinical Tips
Individualizing Botulinum Toxin Dosage
09/06/2024
Benjamin Barankin, MD, FRCPC
Keep these tips and pearls from dermatologic experts in mind for your next appointment.
Keep these tips and pearls from dermatologic experts in mind for your next appointment.
Keep these tips and pearls from...
09/06/2024
The Dermatologist
psoriatic arthritis
News
Early Diagnosis May Be Crucial for Psoriatic Arthritis
09/25/2024
Jessica Garlewicz
One of the primary diagnostic challenges is recognizing early inflammatory signs in the synovium and enthesis.
One of the primary diagnostic challenges is recognizing early inflammatory signs in the synovium and enthesis.
One of the primary diagnostic...
09/25/2024
The Dermatologist
July/August 2026

Current Issue

August 2026
Volume 34
Issue 5
Current Issue
Issue Archive

Latest Quizzes and Trivia

AD
Quiz
Pediatric AD Quiz: Biologic Therapy Challenges in Children
08/10/2026
Riya Gandhi, MA
Assess your understanding of biologic therapy in pediatric atopic dermatitis with this expert quiz. Explore practical barriers to treatment, considerations for young children and caregivers, and real-world factors that influence successful...
Assess your understanding of biologic therapy in pediatric atopic dermatitis with this expert quiz. Explore practical barriers to treatment, considerations for young children and caregivers, and real-world factors that influence successful...
Assess your understanding of...
08/10/2026
The Dermatologist
AD
Quiz
Pediatric AD Quiz: When to Escalate to Systemic Therapy
08/10/2026
Riya Gandhi, MA
Test your knowledge of treatment escalation in pediatric atopic dermatitis. This clinical quiz explores when topical therapy is no longer sufficient and when to initiate systemic treatment in children.
Test your knowledge of treatment escalation in pediatric atopic dermatitis. This clinical quiz explores when topical therapy is no longer sufficient and when to initiate systemic treatment in children.
Test your knowledge of treatment...
08/10/2026
The Dermatologist
Quiz
Type 2 Endotypes and Therapeutic Strategy in Prurigo Nodularis
06/25/2026
Riya Gandhi, MA
Assess advanced concepts in type 2 inflammatory endotypes, shared therapeutic pathways, and practical treatment approaches in prurigo nodularis.
Assess advanced concepts in type 2 inflammatory endotypes, shared therapeutic pathways, and practical treatment approaches in prurigo nodularis.
Assess advanced concepts in type...
06/25/2026
The Dermatologist
itch
Quiz
Fibrosis and Persistent Itch in Prurigo Nodularis
06/15/2026
Riya Gandhi, MA
Test your clinical understanding of fibrotic remodeling and the mechanisms underlying persistent itch and chronic disease activity in prurigo nodularis.
Test your clinical understanding of fibrotic remodeling and the mechanisms underlying persistent itch and chronic disease activity in prurigo nodularis.
Test your clinical understanding...
06/15/2026
The Dermatologist
brain
Quiz
Neuroimmune Mechanisms and Cytokine Signaling in Prurigo Nodularis
06/05/2026
Riya Gandhi, MA
Explore advanced concepts in neuroimmune communication, cytokine-driven itch amplification, and fibrotic signaling pathways involved in prurigo nodularis.
Explore advanced concepts in neuroimmune communication, cytokine-driven itch amplification, and fibrotic signaling pathways involved in prurigo nodularis.
Explore advanced concepts in...
06/05/2026
The Dermatologist
Quiz
Predicting Disease Severity and Persistence in Pediatric Atopic Dermatitis
04/15/2026
Riya Gandhi, MA
Test your expertise in identifying risk factors for persistent pediatric atopic dermatitis and understanding the interplay between barrier dysfunction and immune dysregulation.
Test your expertise in identifying risk factors for persistent pediatric atopic dermatitis and understanding the interplay between barrier dysfunction and immune dysregulation.
Test your expertise in...
04/15/2026
The Dermatologist
Quiz
Type 2 Inflammation and Early Systemic Therapy in Pediatric Atopic Dermatitis
04/05/2026
Riya Gandhi, MA
Assess advanced clinical reasoning in pediatric atopic dermatitis, including implications of type 2 inflammation for diagnosis, treatment timing, and systemic therapy decisions.
Assess advanced clinical reasoning in pediatric atopic dermatitis, including implications of type 2 inflammation for diagnosis, treatment timing, and systemic therapy decisions.
Assess advanced clinical...
04/05/2026
The Dermatologist
Quiz
Disease Heterogeneity in PN
03/15/2026
Riya Gandhi, MA
Challenge your understanding of direct and indirect cytokine–nerve interactions and mechanical hypersensitivity of type 2 signaling in prurigo nodularis.
Challenge your understanding of direct and indirect cytokine–nerve interactions and mechanical hypersensitivity of type 2 signaling in prurigo nodularis.
Challenge your understanding of...
03/15/2026
The Dermatologist
Quiz
Rethinking Severity and JAK Inhibitor Strategy in Alopecia Areata
03/12/2026
Riya Gandhi, MA
How should clinicians redefine severe alopecia areata? When is it appropriate to treat ≤20% scalp involvement with oral JAK inhibitors? This expert-level quiz explores remission durability, treatment withdrawal, and practical strategies for...
How should clinicians redefine severe alopecia areata? When is it appropriate to treat ≤20% scalp involvement with oral JAK inhibitors? This expert-level quiz explores remission durability, treatment withdrawal, and practical strategies for...
How should clinicians redefine...
03/12/2026
The Dermatologist
Quiz
Cytokine Hierarchy and Sustained Pruritus in PN
03/10/2026
Riya Gandhi, MA
Explore the hierarchical and cooperative roles of IL-4, IL-13, and IL-31 in sustaining chronic itch and inflammation in prurigo nodularis.
Explore the hierarchical and cooperative roles of IL-4, IL-13, and IL-31 in sustaining chronic itch and inflammation in prurigo nodularis.
Explore the hierarchical and...
03/10/2026
The Dermatologist

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use